Jesper Bøje Andersen
Prof. Jesper B. Andersen received his PhD in 2006 from the Department of Molecular and Structural Biology at Aarhus University, Denmark, following a research fellowship (2003–2007) in the laboratory of Dr. Bret A. Hassel at the University of Maryland, Marlene and Stewart Greenebaum Cancer Center Baltimore, USA. From 2007 to 2014, he joined the Section of Snorri S. Thorgeirsson at the National Cancer Institute, NIH, USA. In 2014, he started his own laboratory as Associate Professor at Biotech Research and Innovation Centre (BRIC), Faculty of Health and Medical Sciences, University of Copenhagen, Denmark. He was tenured in 2019 and appointed full professor in Translational Hepatology at University of Copenhagen, Denmark in 2023.
Jesper has published more than 130 seminal papers and book chapters, received several prestigious merit awards and fellowships in cancer research, most recently from the Danish Cancer Society, 2015 and the Novo Nordisk Foundation Research Leader Program, 2022. His laboratory has received many competitive investigator awards and grants from Danish and European funding agencies, including the Independent Research Fund Denmark, Medical Research for elite science in Denmark, European Association for the Study of the Liver (EASL) Sheila Sherlock and multiple Marie Sklodowska-Curie European postdoctoral fellowships. Jesper is the founder and former director of BRICs postdoc career program (PCP) and vivid mentor in numerous national and international mentor-mentee programs. He is the co-founder of the European Network for the Study of Cholangiocarcinoma (ENSCCA), Global Cholangiocarcinoma Alliance, several European COST action networks, and patient outreach-focused programs within primary liver cancers. He is an active participant in the Cholangiocarcinoma Foundation USA, and member of the International Cholangiocarcinoma Research Network (ICRN). Prof. Andersen is past editor at Hepatology (2017-2020) and currently serves as associate editor for Journal of Hepatology (2019-).